NasdaqGS - Delayed Quote USD
Repare Therapeutics Inc. (RPTX)
1.4500
0.0000
(0.00%)
At close: June 4 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 72,100 | 4 |
| Sales | 37,270 | 4 |
| Net Shares Purchased (Sold) | 34,830 | 8 |
| Total Insider Shares Held | 536.14k | -- |
| % Net Shares Purchased (Sold) | 6.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ALVES SANDRA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 2, 2025 |
| SEGAL LLOYD MITCHELL Chief Executive Officer | Sale at price 1.14 per share. | Direct | 24,144 | Mar 12, 2025 |
| ZINDA MICHAEL Officer | Sale at price 1.14 per share. | Direct | 6,397 | Mar 12, 2025 |
| FORTE STEVE Chief Financial Officer | Sale at price 1.14 per share. | Direct | 7,848 | Mar 12, 2025 |
| KOEHLER MARIA Officer | Sale at price 1.14 per share. | Direct | 4,099 | Mar 12, 2025 |
| SEGAL LLOYD MITCHELL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2025 |
| ZINDA MICHAEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2025 |
| FORTE STEVE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 4, 2025 |
| SEGAL LLOYD MITCHELL Chief Executive Officer | Sale at price 4.62 - 4.63 per share. | Indirect | 23,776 | Apr 1, 2024 |
| ZINDA MICHAEL Officer | Sale at price 4.64 - 4.66 per share. | Direct | 3,999 | Apr 1, 2024 |
| FORTE STEVE Chief Financial Officer | Sale at price 4.61 - 4.62 per share. | Direct | 7,449 | Apr 1, 2024 |
| KOEHLER MARIA Officer | Sale at price 4.64 - 4.66 per share. | Direct | 3,718 | Apr 1, 2024 |
| SEGAL LLOYD MITCHELL Chief Executive Officer | Sale at price 4.63 - 4.79 per share. | Indirect | 37,259 | Mar 27, 2024 |
| ZINDA MICHAEL Officer | Sale at price 4.61 - 4.78 per share. | Direct | 6,304 | Mar 27, 2024 |
| FORTE STEVE Chief Financial Officer | Sale at price 4.60 - 4.79 per share. | Direct | 11,558 | Mar 27, 2024 |
| KOEHLER MARIA Officer | Sale at price 4.60 - 4.78 per share. | Direct | 7,000 | Mar 27, 2024 |
| SEGAL LLOYD MITCHELL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| ZINDA MICHAEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| FORTE STEVE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| KOEHLER MARIA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| KOEHLER MARIA Officer | Conversion of Exercise of derivative security at price 2.06 - 2.42 per share. | Direct | 98,755 | Dec 11, 2023 |
| BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 5.00 - 5.38 per share. | Indirect | 6,249,889 | Nov 16, 2023 |
| BVF PARTNERS L P Beneficial Owner of more than 10% of a Class of Security | Purchase at price 3.60 per share. | Direct | 2,821,352 | Nov 2, 2023 |
| ZINDA MICHAEL Officer | Sale at price 12.02 - 12.03 per share. | Direct | 111,526 | Jun 8, 2023 |
| ZINDA MICHAEL Officer | Sale at price 12.04 per share. | Direct | 14,448 | Jun 6, 2023 |
| SEGAL LLOYD MITCHELL Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2023 |
| ZINDA MICHAEL Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2023 |
| FORTE STEVE Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2023 |
| KOEHLER MARIA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2023 |
| KOEHLER MARIA Officer | Conversion of Exercise of derivative security at price 2.06 - 2.42 per share. | Direct | 100,040 | Dec 20, 2022 |
| JEREL DAVIS C Director | Sale at price 16.00 per share. | Indirect | 4,000,000 | Dec 9, 2022 |
| BVF PARTNERS L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.73 per share. | Indirect | 1,898,820 | Jun 13, 2022 |
| BVF PARTNERS L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 11.68 - 13.21 per share. | Indirect | 21,859,329 | Jun 6, 2022 |
| JEREL DAVIS C Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 12.25 per share. | Indirect | 9,188,775 | Jun 3, 2022 |
| BVF PARTNERS L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 8.50 per share. | Indirect | 3,570,000 | May 18, 2022 |
| ZINDA MICHAEL Officer | Sale at price 11.30 per share. | Direct | 6,023 | Mar 15, 2022 |
| BVF PARTNERS L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 14.10 per share. | Indirect | 14,071,250 | Jan 19, 2022 |
| KOEHLER MARIA Officer | Conversion of Exercise of derivative security at price 2.06 - 2.42 per share. | Direct | 100,048 | Dec 10, 2021 |
| ZINDA MICHAEL Officer | Conversion of Exercise of derivative security at price 1.64 - 2.42 per share. | Direct | 91,948 | Nov 23, 2021 |
| CIVIK THOMAS Director | Purchase at price 28.08 per share. | Direct | 210,600 | Nov 16, 2021 |
| ZINDA MICHAEL Officer | Sale at price 27.20 - 27.87 per share. | Direct | 546,613 | Nov 15, 2021 |
| ORBIMED ADVISORS, L.L.C. Unknown | Sale at price 33.93 - 34.00 per share. | Indirect | 274,794 | Sep 7, 2021 |
| BONITA DAVID P. M.D. Director | Sale at price 33.93 - 34.00 per share. | Indirect | 274,794 | Sep 7, 2021 |
| ORBIMED ADVISORS, L.L.C. Unknown | Sale at price 33.94 - 34.24 per share. | Indirect | 1,290,550 | Sep 2, 2021 |
| BONITA DAVID P. M.D. Director | Sale at price 33.94 - 34.24 per share. | Indirect | 1,290,550 | Sep 2, 2021 |
| ORBIMED ADVISORS, L.L.C. Unknown | Sale at price 33.92 - 34.52 per share. | Indirect | 615,748 | Aug 30, 2021 |
| BONITA DAVID P. M.D. Director | Sale at price 33.92 - 34.52 per share. | Indirect | 615,748 | Aug 30, 2021 |
| ORBIMED ADVISORS, L.L.C. Director | Sale at price 34.06 - 34.34 per share. | Indirect | 622,426 | Aug 25, 2021 |
| BONITA DAVID P. M.D. Director | Sale at price 34.06 - 34.34 per share. | Indirect | 622,426 | Aug 25, 2021 |
| ORBIMED ADVISORS, L.L.C. Unknown | Sale at price 33.99 - 34.12 per share. | Indirect | 693,210 | Aug 18, 2021 |
Related Tickers
LVTX LAVA Therapeutics N.V.
1.2900
-2.27%
IKNA Ikena Oncology, Inc.
1.3400
-0.74%
EPIX ESSA Pharma Inc.
1.7100
0.00%
HLVX HilleVax, Inc.
1.9800
+1.02%
PMVP PMV Pharmaceuticals, Inc.
0.9300
+1.16%
CRGX CARGO Therapeutics, Inc.
4.5500
+1.11%
NERV Minerva Neurosciences, Inc.
1.8500
+5.41%
SYBX Synlogic, Inc.
1.2300
+5.13%
TBPH Theravance Biopharma, Inc.
11.01
-0.99%
ANTX AN2 Therapeutics, Inc.
1.0900
-0.91%